VOISIN Consulting Australia’s
VX-770 has been added to the
TGAs list of authorised Orphan Drugs.
Designed to improve pulmonary
function in cystic fibrosis patients
who have at least one allele with a
G551D-CF transmembrane
conductance regulator gene
(CFTR) mutation or homozygous
for F508del-CFTR mutation.
VX-770 is now available in 100mg
and 150mg film coated tablets.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jun 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jun 10
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.